Saturday, September 5, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· May 20, 2026

Analog Devices Inc (ADI) Q2 2026 Earnings Call Highlights: Record Revenue and Strategic ...

View original at finance.yahoo.com
“Cash and Short-term Investments: $3.4 billion.”
Verbatim excerpt from the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Communications revenue represented 15% of total revenue, up 22% sequentially and 79% year over year.

    60% confidence
  • Third-quarter 2026 revenue is expected to be $3.9 billion, plus or minus $100 million.

    60% confidence
  • Automotive revenue represented 24% of total revenue, up 8% sequentially and 2% year over year.

    60% confidence
  • The acquisition of Empower Semiconductor is not expected to contribute materially to revenue in the near term.

    60% confidence
  • Inventory increased by $81 million sequentially, with days of inventory at 168.

    60% confidence
  • There are concerns about potential choke points in the semiconductor supply chain, particularly in memory, which could affect consumer customers.

    60% confidence
  • There is a potential risk of increased competition in pricing as some competitors may use the inflationary environment to take shares.

    60% confidence
  • Operating margin reached 49%, up 350 basis points sequentially and 780 basis points year over year.

    60% confidence
  • Cash and short-term investments totaled $3.4 billion as of Q2 2026.

    60% confidence
  • Third-quarter 2026 operating margin is expected to be 49%, plus or minus 100 basis points.

    60% confidence
  • Third-quarter 2026 EPS is expected to be $3.30, plus or minus $0.15.

    60% confidence
  • A 50 basis point decline in gross margin is anticipated for the third quarter due to the absence of a one-time benefit from repricing the channel.

    60% confidence
  • ADI is seeing strong demand in AI-driven infrastructure investments, particularly in data center and ATE businesses.

    60% confidence
  • Industrial revenue represented 50% of total revenue, up 20% sequentially and 56% year over year.

    60% confidence
  • Revenue for Q2 2026 was $3.62 billion, up 15% sequentially and 37% year over year, representing a record quarter and exceeding the high end of guidance.

    60% confidence
  • Consumer revenue is expected to decline single digits sequentially in the third quarter due to inflationary pressures and consumer sentiment.

    60% confidence
  • Consumer revenue represented 11% of total revenue, flat sequentially and up 23% year over year.

    60% confidence
  • Gross margin improved to 73%, up 180 basis points sequentially and 360 basis points year over year, driven by favorable mix, higher utilization, and pricing.

    60% confidence
  • Free cash flow over the trailing 12 months was $4.6 billion, representing 36% of revenue.

    60% confidence
  • EPS for Q2 2026 was $3.09, up 26% sequentially and 67% year over year.

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com